SYNGENEHealthcare Research, Analytics & Technology
Syngene International Ltd — PE Ratio & Valuation Analysis
₹389.90
-1.04%
Current P/E55.50xPrice to earnings
Industry P/E45.95xSector average
4Y Avg P/E60.2x7.8% below avg
⚠️
20.8% Premium to Industry
SYNGENE P/E 55.50x vs sector avg 45.95x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹12.34 | ₹651 | 52.8x |
| 2024 | ₹12.69 | ₹858 | 67.6x |
| 2023 | ₹11.51 | ₹701 | 60.9x |
| 2022 | ₹9.82 | ₹586 | 59.6x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Syngene International Ltd Valuation
Syngene International Ltd (SYNGENE) currently trades at 55.50x earnings. The Healthcare Research, Analytics & Technology sector average PE is 45.95x. SYNGENE commands a premium, reflecting high growth expectations. Historically, SYNGENE has traded at an average PE of 60.2x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
10.53%
Dividend Yield
0.19%
More on Syngene International Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.